Use of medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia

Public Health Reports

Volumn 126, Issue SUPPL. 3, 2011, Pages 89-101

  Walkup, James ^a   Akincigil, Ayse ^b   Hoover, Donald R ^a   Siegel, Michele J ^a   Amin, Shahla ^c   Crystal, Stephen ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CRIME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MEDICAID; PATIENT CODING; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SOCIOECONOMICS; SUBSTANCE ABUSE; PREVALENCE; SOCIOLOGY; STATISTICS; UNITED STATES;

CRIME; HIV INFECTIONS; HUMANS; MEDICAID; PREVALENCE; SCHIZOPHRENIA; SOCIOECONOMIC FACTORS; SOCIOLOGY, MEDICAL; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 80655145186     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/00333549111260s314     Document Type: Article

References (87)

1. Parks J, Svendsen D, Singer P, Foti ME. Morbidity and mortality in people with serious mental illness. Thirteenth in a series of technical reports. Alexandria (VA): National Association of State Mental Health Program Directors; 2006.
2. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006;3:A42.
3. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123-31.
4. Weber NS, Cowan DN, Millikan AM, Niebuhr DW. Psychiatric and general medical conditions comorbid with schizophrenia in the National Hospital Discharge Survey. Psychiatr Serv 2009;60:1059-67.
5. von Hausswolff-Juhlin Y, Bjartveit M, Lindstrom E, Jones P. Schizophrenia and physical health problems. Acta Psychiatr Scand Suppl 2009;(438):15-21.
6. Braveman P. Health disparities and health equity: concepts and measurement. Annu Rev Public Health 2006;27:167-94.
7. Adler NE, Rehkopf DH. U.S. disparities in health: descriptions, causes, and mechanisms. Annu Rev Public Health 2008;29:235-52.
8. Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv 2002;53:868-73.
9. Crystal S, Akincigil A, Bilder S, Walkup JT. Studying prescription drug use and outcomes with Medicaid claims data: strengths, limitations, and strategies. Med Care 2007;45(10 Suppl 2):S58-65.
10. Hoover DR, Sambamoorthi U, Walkup JT, Crystal S. Mental illness and length of inpatient stay for Medicaid recipients with AIDS. Health Serv Res 2004;39:1319-39.
11. Walkup J, Wei W, Sambamoorthi U, Crystal S. Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q 2008;79:43-53.
12. Walkup J, Crystal S, Sambamoorthi U. Schizophrenia and major affective disorder among Medicaid recipients with HIV/AIDS in New Jersey. Am J Public Health 1999;89:1101-3.
13. Nakashima AK, Fleming PL. HIV/AIDS surveillance in the United States, 1981-2001. J Acquir Immune Defic Syndr 2003;32 Suppl 1:S68-85.
14. Sullivan PS, McKenna MT, Janssen RS. Progress toward implementation of integrated systems for surveillance of HIV infection and morbidity in the United States. Public Health Rep 2007;122 Suppl 1:1-3.
15. McNaghten AD, Wolfe MI, Onorato I, Nakashima AK, Valdiserri RO, Mokotoff E, et al. Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach. PLoS One 2007;2:e550.
16. Holmes WC, Bix B, Meritz M, Turner J, Hutelmyer C. Human immunodeficiency virus (HIV) infection and quality of life: the potential impact of Axis I psychiatric disorders in a sample of 95 HIV seropositive men. Psychosom Med 1997;59:187-92.
17. Williams JB, Rabkin JG, Remien RH, Gorman JM, Ehrhardt AA. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection: II. Standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry 1991;48:124-30.
18. Cournos F, McKinnon K. HIV seroprevalence among people with severe mental illness in the United States: a critical review. Clin Psychol Rev 1997;17:259-69.
19. Carey MP, Cournos F. HIV and AIDS among the severely mentally ill: introduction to the special series. Clin Psychol Rev 1997;17:241-5.
20. McKinnon K, Carey MP, Cournos F. Research on HIV, AIDS, and severe mental illness: recommendations from the NIMH National Conference. Clin Psychol Rev 1997;17:327-31.
21. Beyer JL, Taylor L, Gersing KR, Krishnan KR. Prevalence of HIV infection in a general psychiatric outpatient population. Psychosomatics 2007;48:31-7.
22. Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001;91:31-7.
23. Himelhoch S, McCarthy JF, Ganoczy D, Medoff D, Dixon LB, Blow FC. Understanding associations between serious mental illness and HIV among patients in the VA Health System. Psychiatr Serv 2007;58:1165-72.
24. Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv 2002;53:868-73.
25. Stoskopf CH, Kim YK, Glover SH. Dual diagnosis: HIV and mental illness, a population-based study. Community Ment Health J 2001;37:469-79.
26. Carey MP, Carey KB, Kalichman SC. Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses. Clin Psychol Rev 1997;17:271-91.
27. Carey MP, Carey KB, Maisto SA, Gleason JR, Gordon CM, Brewer KK. HIV risk behavior among outpatients at a state psychiatric hospital: prevalence and risk modeling. Behavior Ther 1999;30:389-406.
28. McKinnon K, Cournos F, Herman R. A lifetime alcohol or other drug use disorder and specific psychiatric symptoms predict sexual risk for HIV infection among people with severe mental illness. AIDS Behav 2001;5:233-40.
29. Meade CS, Sikkema KJ. Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. Community Ment Health J 2007;43:153-69.
30. Gottesman II, Groome CS. HIV/AIDS risks as a consequence of schizophrenia. Schizophr Bull 1997;23:675-84.
31. Meade CS, Weiss RD. Substance abuse as a risk factor for HIV sexual risk behavior among persons with severe mental illness: review of evidence and exploration of mechanisms. Clin Psychol 2007;14:23-33.
32. Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev 2005;25:433-57.
33. Tucker JS, Kanouse DE, Miu A, Koegel P, Sullivan G. HIV risk behaviors and their correlates among HIV-positive adults with serious mental illness. AIDS Behav 2003;7:29-40.
34. Kelly JA. HIV risk reduction interventions for persons with severe mental illness. Clin Psychol Rev 1997;17:293-309.
35. Berkman A, Pilowsky DJ, Zybert PA, Herman DB, Conover S, Lemelle S, et al. HIV prevention with severely mentally ill men: a randomised controlled trial. AIDS Care 2007;19:579-88.
36. Castor D, Pilowsky DJ, Hadden B, Fuller C, Ompad DC, de Leon CL, et al. Sexual risk reduction among non-injection drug users: report of a randomized controlled trial. AIDS Care 2010;22:62-70.
37. Berkman A, Pilowsky DJ, Zybert PA, Leu CS, Sohler N, Susser E. The impact of substance dependence on HIV sexual risk-reduction among men with severe mental illness. AIDS Care 2005;17:635-9.
38. Carey MP, Carey KB, Maisto SA, Schroder KE, Vanable PA, Gordon CM. HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and gender. J Nerv Ment Dis 2004;192:289-96.
39. Carey MP, Carey KB, Kalichman SC. Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses. Clin Psychol Rev 1997;17:271-91.
40. Rosenberg SD, Trumbetta SL, Mueser KT, Goodman LA, Osher FC, Vidaver RM, et al. Determinants of risk behavior for human immunodeficiency virus/acquired immunodeficiency syndrome in people with severe mental illness. Compr Psychiatry 2001;42:263-71.
41. Krakow DS, Galanter M, Dermatis H, Westreich LM. HIV risk factors in dually diagnosed patients. Am J Addict 1998;7:74-80.
42. Silberstein C, Galanter M, Marmor M, Lifshutz H, Krasinski K, Franco H. HIV-1 among inner city dually diagnosed inpatients. Am J Drug Alcohol Abuse 1994;20:101-13.
43. Frank RG, McGuire TG, Regier DA, Manderscheid R, Woodward A. Paying for mental health and substance abuse care. Health Aff (Millwood) 1994;13:337-42.
44. Mark TL, Coffey RM, Vandivort-Warren R, Harwood HJ, King EC; MHSA Spending Estimates Team. U.S. spending for mental health and substance abuse treatment, 1991-2001. Health Aff (Millwood) 2005;Suppl Web Exclusives:W5-133-W5-142.
45. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med 2005;61:1026-44.
46. Centers for Disease Control and Prevention (US). HIV/AIDS surveillance report, 2001 (Vol. 13). Atlanta: CDC; 2001.
47. Susser E, Miller M, Valencia E, Colson P, Roche B, Conover S. Injection drug use and risk of HIV transmission among homeless men with mental illness. Am J Psychiatry 1996;153:794-8.
48. Roberts ET, Friedman SR, Brady JE, Pouget ER, Tempalski B, Galea S. Environmental conditions, political economy, and rates of injection drug use in large US metropolitan areas 1992-2002. Drug Alcohol Depend 2010;106:142-53.
49. Tempalski B, McQuie H. Drugscapes and the role of place and space in injection drug use-related HIV risk environments. Int J Drug Policy 2009;20:4-13.
50. Department of Health and Human Services (US), Centers for Medicare and Medicaid Services. Medicaid Analytic eXtract (MAX) general information [cited 2008 Jan 10]. Available from: URL: http://www.resdac.org/Medicaid/data_available.asp
51. Lurie N, Popkin M, Dysken M, Moscovice I, Finch M. Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Community Psychiatry 1992;43:69-71.
52. Walkup JT, Boyer CA, Kellermann SL. Reliability of Medicaid claims files for use in psychiatric diagnoses and service delivery. Adm Policy Ment Health 2000;27:129-39.
53. Bagchi A, Sambamoorthi U, McSpiritt E, Yanos P, Walkup J, Crystal S. Use of antipsychotic medications among HIV-infected individuals with schizophrenia. Schizophr Res 2004;71:435-44.
54. Sambamoorthi U, Walkup J, McSpiritt E, Warner L, Castle N, Crystal S. Racial differences in end-of-life care for patients with AIDS. AIDS Public Policy J 2000;15:136-48.
55. Walkup J, Akincigil A, Bilder S, Rosato NS, Crystal S. Psychiatric diagnosis and antiretroviral adherence among adolescent Medicaid beneficiaries diagnosed with human immunodeficiency virus/acquired immunodeficiency syndrome. J Nerv Ment Dis 2009;197:354-61.
56. Walkup J, Sambamoorthi U, Crystal S. Incidence and consistency of antiretroviral use among HIV-infected Medicaid beneficiaries with schizophrenia. J Clin Psychiatry 2001;62:174-8.
57. Walkup JT, Wei W, Sambamoorthi U, Crystal S. Sensitivity of an AIDS case-finding algorithm: who are we missing? Med Care 2004;42:756-63.
58. Centers for Disease Control and Prevention (US). AIDS public information data set [manual] [cited 2009 Aug 26]. Available from: URL: http://www.cdc.gov/hiv/topics/surveillance/resources/ software/apids/manual/pdf/pids2002.pdf
59. Centers for Disease Control and Prevention (US). HIV/AIDS surveillance report, 2003 (Vol. 15) [cited 2009 Dec 18]. Available from: URL: http://www.cdc.gov/hiv/stats/hasrlink.htm
60. Census Bureau (US). American FactFinder [cited 2008 Apr 3]. Available from: URL: http://factfinder.census.gov/home/saff/ main.html?_lang5en
61. Tempalski B, Lieb S, Cleland CM, Cooper H, Brady JE, Friedman SR. HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002. J Urban Health 2009;86:132-54.
62. Department of Housing and Urban Development (US). State of the cities data systems (SOCDS) [cited 2009 Aug 27]. Available from: URL: http://socds.huduser.org/SOCDS_Home.htm
63. Department of Justice (US), Federal Bureau of Investigation. Uniform Crime Reporting program data [United States]: county-level detailed arrest and offense data. Washington: Department of Justice, FBI; 2009.
64. Department of Health and Human Services (US), Substance Abuse and Mental Health Services Administration. DASIS [Drug & Alcohol Services Information System]. National Survey of Substance Abuse Treatment Services (N-SSATS) [cited 2008 Feb 1]. Available from: URL: http://wwwdasis.samhsa.gov/dasis2/nssats.htm
65. Brady JE, Friedman SR, Cooper HL, Flom PL, Tempalski B, Gostnell K. Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. J Urban Health 2008;85:323-51.
66. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: the Public Health Disparities Geocoding Project. Am J Public Health 2005;95:312-23.
67. Krieger N, Waterman PD, Chen JT, Soobader MJ, Subramanian SV. Monitoring socioeconomic inequalities in sexually transmitted infections, tuberculosis, and violence: geocoding and choice of area-based socioeconomic measures-the Public Health Disparities Geocoding Project (US). Public Health Rep 2003;118:240-60.
68. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 1997;18:341-78.
69. SAS Institute, Inc. SAS®: Version 9.2. Cary (NC): SAS Institute, Inc.; 2008.
70. StataCorp LP. Stata®: Version 9.2. College Station (TX): StataCorp LP; 2006.
71. Garfein RS, Monterroso ER, Tong TC, Vlahov D, Des Jarlais DC, Selwyn P, et al. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health 2004;81:260-7.
72. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996;86:642-54.
73. Friedman SR, Lieb S, Tempalski B, Cooper H, Keem M, Friedman R, et al. HIV among injection drug users in large US metropolitan areas, 1998. J Urban Health 2005;82:434-45.
74. Friedman SR, Tempalski B, Cooper H, Perlis T, Keem M, Friedman R, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health 2004;81:377-400.
75. Perry BL, Wright ER. The sexual partnerships of people with serious mental illness. J Sex Res 2006;43:174-81.
76. Wright ER, Wright DE, Perry BL, Foote-Ardah CE. Stigma and the sexual isolation of people with serious mental illness. Soc Problems 2007;54:78-98.
77. Dinwiddie SH, Cottler L, Compton W, Abdallah AB. Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. Drug Alcohol Depend 1996;43:1-11.
78. Lipsitz JD, Williams JB, Rabkin JG, Remien RH, Bradbury M, el Sadr W, et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry 1994;151:1662-8.
79. Rabkin JG, Johnson J, Lin SH, Lipsitz JD, Remien RH, Williams JB, et al. Psychopathology in male and female HIV-positive and negative injecting drug users: longitudinal course over three years. AIDS 1997;11:507-15.
80. Kidorf M, Disney ER, King VL, Neufeld K, Beilenson PL, Brooner RK. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend 2004;74:115-22.
81. Ryan White Comprehensive AIDS Resources Emergency (CARE) Act. Pub. L. No. 101-381, 104 Stat. 576 (1990).
82. The Henry J. Kaiser Family Foundation. HIV/AIDS policy fact sheet: AIDS Drug Assistance Programs (ADAPs), April 2008 [cited 2010 Jun 1]. Available from: URL: http://www.kff.org/hivaids/ upload/1584_09.pdf
83. Walkup JT, Crystal S. Mental health and the changing contexts of HIV. In: Scheid TL, Brown TN, editors. A handbook for the study of mental health: social contexts, theories, and systems. 2nd ed. New York: Cambridge University Press; 2009. p. 548-70.
84. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care STDS 2003;17:179-86.
85. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care 2004;16:501-6.
86. Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Abdul-Quader A, Heckathorn DD, et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007;21:231-5.
87. Des Jarlais DC, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, et al. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr 2004;35:158-66.